Literature DB >> 8856583

Frequency and clinical pattern of celiac disease among siblings of celiac children.

M Bonamico1, P Mariani, M C Mazzilli, P Triglione, P Lionetti, P Ferrante, A Picarelli, A Mesturino, G Gemme, C Imperato.   

Abstract

To investigate the prevalence and clinical and genetic patterns of celiac disease (CD) among siblings of CD patients, 103 siblings and one twin of 80 celiac children were evaluated by means of their clinical history, physical examination, blood indices of nutritional status, and antigliadin antibodies (AGA). Antiendomysium antibody (AEA) levels were determined in 70 patients and 85 subjects were human leucocyte antigen (HLA) typed. On the basis of clinical or laboratory data or both, 21 siblings (20.2%) were submitted to intestinal biopsy, whereas intestinal biopsy in six siblings with positive serologic screening (AGA IgA or AEA or both) was not performed because of parental refusal. In a high percentage of cases (18%), all on a gluten-containing diet, the intestinal mucosa was atrophic, and CD was subsequently diagnosed. Because we could not submit all the siblings to intestinal biopsy, this figure could underestimate the real prevalence of the disease in our series; consequently, it was not possible to calculate accurately the sensitivity and specificity of AGA and AEA. Nevertheless, AEA (positive in all the nine siblings with mucosal atrophy), followed by AGA IgA, proved to be the best screening for CD. Eighteen of 19 CD siblings showed HLA-predisposing antigens. Among the 19 CD siblings, one showed a typical form with gastrointestinal symptoms, two had short stature, one suffered from recurrent vomiting, and in 15, the disease was clinically silent. On the contrary, among siblings who were first diagnosed (index cases), the majority (73.7%) had a typical form of CD, and no clinically silent cases were observed. We did not find any difference between index cases and CD siblings in food habits and distribution of HLA antigens. In 15 of 18 cases, the sibling diagnosed subsequently was the older one. Finally, the typical form of CD was significantly more frequent among the younger brother than the older. In conclusion, the high prevalence of the silent form of CD in our cases indicates that siblings of CD subjects should always be screened for CD. The combination of AGA IgA and AEA represent a good screening method to use in selecting children for the intestinal biopsy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856583     DOI: 10.1097/00005176-199608000-00011

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group.

Authors:  C Farré; P Humbert; P Vilar; V Varea; X Aldeguer; J Carnicer; M Carballo; M A Gassull
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 2.  Genetic factors underlying gluten-sensitive enteropathy.

Authors:  A S Peña; C Wijmenga
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

3.  Anti-alpha-gliadin antibodies (AGA) in the serum of coeliac children and controls recognize an identical collection of linear epitopes of alpha-gliadin.

Authors:  M ten Dam; Y Van De Wal; M L Mearin; Y Kooy; S Peña; J W Drijfhout; F Koning; M Van Tol
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

Review 4.  Risk of Celiac Disease in the First- and Second-Degree Relatives of Patients With Celiac Disease: A Systematic Review and Meta-Analysis.

Authors:  Prashant Singh; Shubhangi Arora; Suman Lal; Tor A Strand; Govind K Makharia
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

5.  HLA related genetic risk for coeliac disease.

Authors:  Mathieu Bourgey; Giuseppe Calcagno; Nadia Tinto; Daniela Gennarelli; Patricia Margaritte-Jeannin; Luigi Greco; Maria Giovanna Limongelli; Oscar Esposito; Caterina Marano; Riccardo Troncone; Antonella Spampanato; Françoise Clerget-Darpoux; Lucia Sacchetti
Journal:  Gut       Date:  2007-03-07       Impact factor: 23.059

6.  Family recognition of celiac disease.

Authors:  Dorota Szałowska; Leokadia Bąk-Romaniszyn
Journal:  Prz Gastroenterol       Date:  2013-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.